Profile data is unavailable for this security.
About the company
U.S. Physical Therapy, Inc. is engaged in physical therapy operations and provides industrial injury prevention services. The Company is engaged in physical therapy operations primarily through its subsidiary, clinic partnerships. The Company's physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. It operates approximately 678 outpatient physical therapy clinics in 42 states. The Company's industrial injury prevention services include onsite injury prevention and rehabilitation, performance optimization, post offer employment testing, functional capacity evaluations, and ergonomic assessments. It performs these services through Industrial Sports Medicine Professionals, consisting primarily of specialized certified athletic trainers (ATCs).
- Revenue in USD (TTM)604.80m
- Net income in USD18.14m
- Incorporated1992
- Employees3.90k
- LocationUS Physical Therapy Inc1300 West Sam Houston Parkway, Suite 300HOUSTON 77043United StatesUSA
- Phone+1 (713) 297-7000
- Fax+1 (713) 297-7090
- Websitehttps://www.usph.com/
Mergers & acquisitions
Acquired company | USPH:NYQ since announced | Transaction value |
---|---|---|
Undisclosed Physical Therapy & Hand Therapy Practice(9) | -11.07% | 16.40m |
Undisclosed Physical Therapy Practice(2) | 9.43% | 13.90m |
Undisclosed Clinic Physical Therapy Practice(5) | -13.67% | 2.10m |
Undisclosed Four-Clinic Physical Therapy Practice Co | 0.70% | 3.10m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alignment Healthcare Inc | 1.82bn | -148.02m | 975.12m | 1.54k | -- | 6.21 | -- | 0.5347 | -0.7944 | -0.7944 | 9.79 | 0.8306 | 2.98 | -- | 39.26 | 1,187,259.00 | -24.18 | -- | -40.57 | -- | 11.02 | -- | -8.13 | -- | -- | -5.88 | 0.5059 | -- | 27.16 | -- | 1.02 | -- | -- | -- |
Brookdale Senior Living, Inc. | 3.02bn | -189.01m | 1.30bn | 25.20k | -- | 3.20 | 8.05 | 0.4307 | -0.8392 | -0.8392 | 13.39 | 2.14 | 0.524 | -- | 57.91 | 119,675.80 | -3.29 | -2.20 | -3.68 | -2.48 | 24.76 | 21.71 | -6.27 | -4.40 | -- | 0.1213 | 0.9048 | -- | 6.74 | -7.82 | 20.73 | -- | -12.60 | -- |
National HealthCare Corporation | 1.14bn | 66.80m | 1.40bn | 13.12k | 20.94 | 1.53 | 13.02 | 1.22 | 4.34 | 4.34 | 74.23 | 59.20 | 0.8828 | 98.43 | 10.95 | 86,988.04 | 5.05 | 5.12 | 6.02 | 6.21 | 37.60 | 39.84 | 5.72 | 6.28 | 1.86 | -- | 0.0009 | 49.35 | 5.14 | 3.09 | 197.61 | 2.03 | -1.29 | 3.43 |
Addus Homecare Corporation | 1.06bn | 62.52m | 1.49bn | 6.06k | 23.91 | 2.11 | 19.42 | 1.41 | 3.84 | 3.84 | 64.96 | 43.55 | 1.08 | -- | 8.79 | 174,723.70 | 6.37 | 5.18 | 7.42 | 6.04 | 32.24 | 30.88 | 5.91 | 4.96 | -- | 9.64 | 0.1494 | 0.00 | 11.31 | 15.43 | 35.83 | 30.83 | 12.06 | -- |
US Physical Therapy Inc | 604.80m | 18.14m | 1.51bn | 3.90k | 74.90 | 3.16 | 28.58 | 2.50 | 1.34 | 1.34 | 42.64 | 31.77 | 0.6519 | -- | 8.74 | 155,117.20 | 4.01 | 7.13 | 5.63 | 10.64 | 20.09 | 21.96 | 6.15 | 9.71 | -- | 16.62 | 0.1836 | 58.53 | 9.34 | 5.91 | -38.01 | 1.78 | 5.26 | 13.33 |
Veracyte Inc | 361.05m | -74.40m | 1.53bn | 815.00 | -- | 1.37 | -- | 4.23 | -1.02 | -1.02 | 4.97 | 14.25 | 0.3179 | 7.42 | 8.56 | 443,007.40 | -6.55 | -6.33 | -6.93 | -6.69 | 68.73 | 67.10 | -20.61 | -20.99 | 4.40 | -- | 0.0001 | -- | 21.76 | 31.45 | -103.51 | -- | 39.67 | -- |
NeoGenomics, Inc. | 591.64m | -87.97m | 1.77bn | 2.10k | -- | 1.87 | -- | 2.99 | -0.7015 | -0.7015 | 4.71 | 7.39 | 0.3459 | 14.33 | 4.68 | 281,734.80 | -5.14 | -3.57 | -5.44 | -3.80 | 41.34 | 41.09 | -14.87 | -9.36 | 5.95 | -- | 0.3637 | -- | 16.07 | 16.41 | 39.02 | -- | 14.98 | -- |
Brightspring Health Services Inc | 8.83bn | -154.60m | 1.78bn | 35.00k | -- | 2.10 | 39.17 | 0.2019 | -0.9204 | -0.9204 | 57.53 | 4.96 | -- | -- | -- | 252,176.40 | -- | -- | -- | -- | 16.24 | 17.75 | -1.78 | -0.6289 | 0.8442 | 0.9783 | 0.8473 | -- | 14.32 | 28.33 | -186.80 | -- | 17.24 | -- |
Astrana Health Inc | 1.39bn | 60.72m | 2.05bn | 1.80k | 28.25 | 2.79 | 27.09 | 1.48 | 1.29 | 1.29 | 29.56 | 13.11 | 1.46 | -- | 11.07 | 770,367.80 | 6.09 | 7.09 | 6.73 | 9.39 | 15.50 | 18.30 | 4.17 | 6.36 | -- | -- | 0.4055 | 10.54 | 21.19 | 21.68 | 34.42 | 41.16 | 89.42 | -- |
Agilon Health Inc | 4.32bn | -195.05m | 2.11bn | 1.12k | -- | 3.15 | -- | 0.4885 | -0.4885 | -0.6576 | 10.51 | 1.63 | 2.51 | -- | 5.99 | 3,864,246.00 | -11.36 | -- | -20.26 | -- | 7.13 | -- | -4.52 | -- | -- | -13,643.82 | 0.0551 | -- | 80.74 | -- | -112.01 | -- | -- | -- |
Privia Health Group Inc | 1.66bn | 23.08m | 2.13bn | 1.10k | 97.13 | 3.79 | 77.45 | 1.29 | 0.1852 | 0.1852 | 13.30 | 4.75 | 1.85 | -- | 6.90 | 1,504,299.00 | 2.35 | -- | 3.91 | -- | 9.74 | 9.15 | 1.27 | -2.56 | -- | -- | 0.00 | -- | 22.19 | 20.31 | 368.83 | -- | -12.48 | -- |
Teladoc Health Inc | 2.62bn | -233.03m | 2.26bn | 5.60k | -- | 0.986 | 17.08 | 0.8617 | -1.40 | -1.40 | 15.80 | 13.52 | 0.607 | 19.58 | 12.18 | 467,732.50 | -5.40 | -33.54 | -5.93 | -34.63 | 70.81 | 68.59 | -8.90 | -171.39 | 3.74 | -- | 0.4021 | -- | 8.13 | 44.16 | 98.39 | -- | 79.43 | -- |
Holder | Shares | % Held |
---|---|---|
BlackRock Fund Advisorsas of 31 Dec 2023 | 2.18m | 14.47% |
Kayne Anderson Rudnick Investment Management LLCas of 31 Dec 2023 | 1.37m | 9.06% |
The Vanguard Group, Inc.as of 31 Dec 2023 | 1.02m | 6.78% |
Copeland Capital Management LLCas of 31 Mar 2024 | 770.22k | 5.11% |
Calvert Research & Managementas of 31 Dec 2023 | 764.39k | 5.07% |
T. Rowe Price Investment Management, Inc.as of 31 Dec 2023 | 761.26k | 5.05% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 562.32k | 3.73% |
Boston Trust Walden, Inc.as of 31 Dec 2023 | 546.96k | 3.63% |
SouthernSun Asset Management LLCas of 31 Dec 2023 | 479.21k | 3.18% |
Schroder Investment Management North America, Inc.as of 31 Dec 2023 | 427.22k | 2.84% |